Low Dose Radiation Therapy
Sponsors
M.D. Anderson Cancer Center, Emory University, All India Institute of Medical Sciences, Juan LI, MD, Fudan University
Conditions
AlzheimerAlzheimer DementiaAlzheimer Dementia (AD)Alzheimer s DiseaseArthritisArthropathyCOVID-19Coronavirus Infection in 2019 (COVID-19)
Phase 1
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
TerminatedNCT04366791
Start: 2020-04-24End: 2022-03-11Updated: 2022-03-29
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
NCT05157542
Start: 2021-06-10End: 2023-06-10Target: 9Updated: 2021-12-15
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
Not yet recruitingNCT07478679
Start: 2026-08-26End: 2028-09-17Target: 20Updated: 2026-03-23
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
RecruitingNCT07619599
Start: 2026-09-14End: 2028-12-22Target: 6Updated: 2026-08-12
Low-Dose Radiotherapy for Alzheimer's Disease
RecruitingNCT07693140
Start: 2026-07-15End: 2029-05-21Target: 50Updated: 2026-07-09
Phase 2
Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Active, not recruitingNCT04054167
Start: 2019-06-14End: 2027-12-31Updated: 2026-06-03
Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy
Not yet recruitingNCT07164690
Start: 2025-09-30End: 2027-07-31Target: 32Updated: 2025-09-10